Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Leiomyosarcoma × olaparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 21 Breast Neoplasms 20 Fallopian Tube Neoplasms 10 Prostatic Neoplasms 8 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Stomach Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pancreatic Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Lung Neoplasms 3 Glioma 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Solid Tumors 2 Sarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Endometrial Neoplasms 2 Cholangiocarcinoma 2 Carcinosarcoma 2 Carcinoma, Squamous Cell 2 Carcinoma, Endometrioid 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1

Interventions

Radiotherapy 3 Radiation 3 pazopanib 2 Nivolumab 2 Doxorubicin 2 talimogene laherparepvec 1 sotigalimab 1 rucaparib 1 ribociclib 1 olaparib 1 futibatinib 1 durvalumab 1 cediranib 1 cabozantinib 1 Temozolomide 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Gemcitabine 1 Everolimus 1 Erlotinib Hydrochloride 1 Biopsy 1 BO-112 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03851614 2026-02-09

DAPPER

University Health Network, Toronto

Phase 2 Active not recruiting

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡